Acciones Advanced Proteome Therapeutics Corp. Toronto S.E.
Acciones
CA0076281009
Holding Companies
Ventas 2021 | - | Ventas 2022 | - | Capitalización | 4,65 M 6,34 M 4,29 M |
---|---|---|---|---|---|
Resultado Neto 2021 | -1 M -1,36 M -923 mil | Resultado Neto 2022 | - 0 0 | VE / Ventas 2021 | - |
Posición de caja neta 2021 | 324 mil 441 mil 299 mil | Posición de caja neta 2022 | 31,61 mil 43,11 mil 29,17 mil | VE / Ventas 2022 | - |
P/E ratio 2021 |
-4,85
x | P/E ratio 2022 |
6,03
x | Empleados | - |
Rendimiento 2021 * |
-
| Rendimiento 2022 |
-
| Flotante | 89,84 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/04/18 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10/03/09 |
Martin Woodward
BRD | Director/Board Member | 56 | 20/12/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20/12/18 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21/11/22 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+66,69 % | 5540,6 M | |
+94,72 % | 1228,88 M | |
+2,57 % | 986 M | |
+32,46 % | 866 M | |
+2,39 % | 668 M | |
-0,36 % | 610 M | |
-.--% | 600 M | |
+10,28 % | 536 M | |
-.--% | 500 M |